IP Library Granted Patent US 7,267,778
Granted Patent B2
US 7,267,778 · App. 10/838,945 · Granted Sep 11, 2007

Device and process for treating a liquid medium

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,267,778
App. No.
10/838,945
Granted
Sep 11, 2007
Kind
B2
Abstract

A device for treating liquid medium has an ultrasound emitter located relative to a compartment of a container holding a liquid medium and a microbubble emitter located relative to the compartment. The ultrasound emitter emits high-frequency ultrasound between about 200 KHz and 10 MHz. The microbubble emitter emits bubbles with an average diameter of less than 1 mm.

Claims (55)

1. A device for treating microorganisms in a liquid medium, comprising:

a reservoir for holding the liquid medium containing microorganisms to be treated, the reservoir being in fluid communication with a compartment;

an ultrasound emitter located relative to the compartment to emit ultrasound into the liquid in the compartment during use of the device, the ultrasound emitter emitting high-frequency ultrasound between about 200 kHz and 10 MHz; and

a microbubble emitter emitting bubbles with an average diameter of less than 1 mm, the microbubble emitter being arranged relative to the compartment so as to emit microbubbles into the high-frequency ultrasound field emitted into the compartment during use of the device, wherein the device is configured to increase sonoluminescence and inhibit a recovery threshold of said microorganisms.

2. A device according to claim 1 , wherein the average diameter of the microbubbles is less than 50 μm.

3. A device according to claim 1 , wherein the microbubble emitter is placed at the base of the compartment and during use of the device the microbubbles move by either rising naturally or by entrainment of the gas microbubbles in the liquid.

4. A device according to claim 1 , further comprising a light emitter located relative to the compartment to emit light into the ultrasound field in the compartment during use of the device, the light emitting electromagnetic radiation mainly in the visible range.

5. A device according to claim 1 , further comprising a means for electromagnetic treatment of the liquid so as to modify at least one of the nucleation, formation and growth of salt crystals during use of the device, said means being placed between the reservoir and the compartment.

6. A device according to claim 1 further comprising one or more means for collecting microorganisms and/or salts present in the treated liquid during use of the device.

7. A device for treating a liquid medium to neutralize, remove and/or prevent the growth of undifferentiated cells and/or of microorganisms present in the liquid medium comprising:

means for placing the liquid medium in fluid communication with a compartment to place medium in the compartment;

means for emitting high-frequency ultrasound between about 200 kHz and 10 MHZ into the medium in the compartment; and

means for emitting microbubbles with an average diameter of less than 1 mm, into the high-frequency ultrasound field emitted into the medium in the compartment, wherein said device is configured to increase sonoluminescence and inhibit a recovery threshold of said cells and/or microorganisms.

8. A device according to claim 7 , further comprising means for electromagnetic treatment of the medium so as to modify at least one of the nucleations, formation and growth of salt crystals in the medium.

9. A method for treating a liquid medium to neutralize, remove and/or prevent the growth of undifferentiated cells and/or of microorganisms present in the liquid medium comprising the steps of:

placing the liquid medium in fluid communication with a compartment to place medium in the compartment;

emitting high-frequency ultrasound between about 200 kHz and 10 MHz into the medium in the compartment;

and emitting microbubbles with an average diameter of less than 1 mm into the high-frequency ultrasound field emitted into the medium in the compartment, so as to increase sonoluminescence and inhibit a recovery threshold of said cells and/or microorganisms.

10. A method according to claim 9 , wherein the microorganisms are selected from the group consisting of bacteria, viruses and algae.

11. A method according to claim 9 , wherein the undifferentiated cells are at least one of cancer cells and bone marrow cells.

12. A method according to claim 11 , comprising the further step of adding reagents to the liquid medium to bring about one of a chemical reaction, precipitation reaction and crystallization reaction.

13. A method according to claim 9 , comprising the further steps of providing a liquid medium containing salts, electromagnetically treating the medium so as to modify at least one of the nucleation, formation and growth of salt crystals in the medium, said means being placed between the reservoir and the compartment, and bringing about a supersaturation of salts in the medium by the emitting ultrasound and microbubbles.

14. A method according to claim 9 , wherein that the supersaturation with salts in the liquid medium comprises the steps of obtaining a salt concentration which is greater than the natural solubility of the salt in the liquid medium of at least 5 times as high as the natural solubility of the salt in the liquid medium.

15. The method of claim 9 , wherein emitting high-frequency ultrasound into the medium in the compartment promotes the formation of radicals.

16. The method of claim 9 , wherein emitting high-frequency ultrasound into the medium in the compartment promotes the formation of hydrogen peroxide.

17. The method of claim 9 , wherein emitting high-frequency ultrasound into the medium in the compartment promotes the formation of molecules toxic to the undifferentiated cells and/or microorganisms present in said medium.

18. A device for treating microorganisms in a liquid medium in an industrial circuit, comprising:

a reservoir for holding the liquid medium to be treated, the reservoir being in fluid communication with a compartment;

an ultrasound emitter located relative to the compartment to emit ultrasound into the liquid in the compartment during use of the device, the ultrasound emitter emitting high-frequency ultrasound between about 200 kHz and 10 MHz; and

a microbubble emitter emitting bubbles with an average diameter of less than 1 mm, the microbubble emitter being arranged relative to the compartment so as to emit microbubbles into the high-frequency ultrasound field emitted into the compartment during use of the device, wherein the device is configured to increase sonoluminescence and inhibit a recovery threshold of said microorganisms.

19. The device of claim 18 , wherein the industrial circuit is a cooling circuit.

20. The device of claim 18 , wherein the industrial circuit is a cooling tower.

21. The device of claim 18 , further comprising a light emitter located relative to the compartment to emit light into the ultrasound field in the compartment during use of the device, the light emitting electromagnetic radiation mainly in the visible range.

22. A method for treating microorganisms in a liquid medium in an industrial circuit comprising:

placing the liquid medium in a compartment;

emitting high-frequency ultrasound between about 200 kHz and 10 MHz into the medium in the compartment with an ultrasound emitter;

emitting microbubbles with an average diameter of less than 1 mm, into the high frequency ultrasound field emitted into the medium in the compartment, so as to increase sonoluminescence and inhibit a recovery threshold of said microorganisms.

23. The method of claim 22 , wherein the industrial circuit is a cooling circuit.

24. The method of claim 22 , wherein the industrial circuit is a cooling tower.

25. The method of claim 22 , wherein the liquid medium contains salts, the method further comprising:

electromagnetically treating the medium so as to modify at least one of the nucleation, formation and growth of salt crystals in the medium, said means being placed between the reservoir and the compartment; and

supersaturating the salts in the medium by emitting ultrasound and microbubbles.

26. A method for ex-vivo treatment of cells in a physiological fluid comprising:

removing said physiological fluid from an organism;

placing said physiological fluid in a treatment compartment without the addition of photosensitizing molecules;

emitting high-frequency ultrasound having a frequency of between about 100 kHz and 10 mHz into the treatment compartment; and

emitting microbubbles with an average diameter of less than 1 mm into the high frequency ultrasound field emitted into the medium in the compartment, so as to increase sonoluminescence and inhibit a recovery threshold of said cells.

27. The method of claim 26 , wherein the high-frequency ultrasound is at a frequency of between 200 kHz and 10 MHz.

28. The method of claim 27 wherein the fluids are selected from the group consisting of one or more of blood, cerebrospinal fluid, aqueous, and vitreous.

29. The method of claim 27 , wherein said fluid is removed from and subsequently introduced into the animal or human body from which it was removed.

30. The method of claim 27 , wherein components of said physiological fluid include undifferentiated cells or microorganisms.

31. The method of claim 30 , wherein the treatment with ultrasound and microbubbles continues for a period of time such that a number of undifferentiated cells or microorganisms are reduced.

32. The method of claim 30 , wherein the undifferentiated cells are selected from the group consisting of bone marrow, tumor cells, and totipotential cells.

33. The method of claim 30 , wherein the microorganisms are selected from the group consisting of one or more of bacteria, viruses, fungi, and parasites.

34. The method of claim 26 , wherein ultraviolet, visible, infrared, laser or microwave energy is also introduced with said ultrasound.

Assignments (17)
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2021
From: CITIBANK, N.A.
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 058848/0636 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2021
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 058856/0724 →
INTELLECTUAL PROPERTY SECOND LIEN SECURITY AGREEMENT RELEASE Recorded Jul 20, 2018
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 047058/0800 →
INTELLECTUAL PROPERTY FIRST LIEN SECURITY AGREEMENT RELEASE Recorded Jul 20, 2018
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 046594/0252 →
FIRST LIEN NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 20, 2018
From: SOLENIS TECHNOLOGIES, L.P.
To: CITIBANK, N.A., COLLATERAL AGENT
Reel/Frame 046595/0241 →
SECOND LIEN NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 20, 2018
From: SOLENIS TECHNOLOGIES, L.P.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 046629/0213 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS (FIRST LIEN) Recorded Aug 14, 2014
From: SOLENIS TECHNOLOGIES, L.P.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 033535/0806 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS (SECOND LIEN) Recorded Aug 14, 2014
From: SOLENIS TECHNOLOGIES, L.P.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 033535/0847 →
U.S. ASSIGNMENT OF PATENTS Recorded Aug 4, 2014
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC
To: SOLENIS TECHNOLOGIES, L.P.
Reel/Frame 033471/0048 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE PATENT NUMBER 6763859 PREVIOUSLY RECORDED ON REEL 016408 FRAME 0950. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 9, 2014
From: ASHLAND INC.
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC
Reel/Frame 032867/0391 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Sep 15, 2011
From: BANK OF AMERICA, N.A.
To: ASHLAND, INC.; ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; HERCULES INCORPORATED
Reel/Frame 026927/0247 →
SECURITY AGREEMENT Recorded Apr 14, 2010
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; HERCULES INCORPORATED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 024225/0289 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2010
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; HERCULES INCORPORATED
Reel/Frame 024218/0928 →
SECURITY AGREEMENT Recorded Dec 3, 2008
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY...; AQUALON COMPANY; HERCULES INCORPORATED
To: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 021924/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2005
From: ASHLAND INC.
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC
Reel/Frame 016408/0950 →